Industry: Service & Software
Published Date: 2026-01-09
Pages: 117 Pages
Report ld: 5618674
Request Sample
Customized Report
The global Cold Chain Services for Innovative Drug market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Cold chain services for innovative drug development refer to temperature-controlled transportation and storage solutions specifically designed for temperature-sensitive drugs, samples, or reagents during the drug development process. These services ensure that drugs and related materials under research maintain optimal temperature conditions throughout the logistics process, preventing any compromise in their activity, stability, or quality due to external temperature fluctuations. The service typically includes refrigerated, frozen, and ultra-low temperature storage, and is applicable to clinical trials, laboratory research, and drug manufacturing.
The North American market for Cold Chain Services for Innovative Drug is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Cold Chain Services for Innovative Drug is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Cold Chain Services for Innovative Drug in Pharmaceutical Companies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Cold Chain Services for Innovative Drug include Marken, World Courier, Cryoport, DTW Logistics, City Express, Shanghai Shengsheng Pharmaceutical Cold Chain Technology, Thermo Fisher, SF Express, Catalent, CIMC Cold Cloud, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Cold Chain Services for Innovative Drug market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cold Chain Services for Innovative Drug. The Cold Chain Services for Innovative Drug market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cold Chain Services for Innovative Drug market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cold Chain Services for Innovative Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Cold Chain Services for Innovative Drug companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cold Chain Services for Innovative Drug Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 International Transportation
1.2.3 Domestic Transportation
1.3 Market by Application
1.3.1 Global Cold Chain Services for Innovative Drug Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Companies
1.3.3 Hospitals
1.3.4 Laboratories
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cold Chain Services for Innovative Drug Market Perspective (2021–2032)
2.2 Global Cold Chain Services for Innovative Drug Growth Trends by Region
2.2.1 Global Cold Chain Services for Innovative Drug Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Cold Chain Services for Innovative Drug Historic Market Size by Region (2021–2026)
2.2.3 Cold Chain Services for Innovative Drug Forecasted Market Size by Region (2027–2032)
2.3 Cold Chain Services for Innovative Drug Market Dynamics
2.3.1 Cold Chain Services for Innovative Drug Industry Trends
2.3.2 Cold Chain Services for Innovative Drug Market Drivers
2.3.3 Cold Chain Services for Innovative Drug Market Challenges
2.3.4 Cold Chain Services for Innovative Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cold Chain Services for Innovative Drug Players by Revenue
3.1.1 Global Top Cold Chain Services for Innovative Drug Players by Revenue (2021–2026)
3.1.2 Global Cold Chain Services for Innovative Drug Revenue Market Share by Players (2021–2026)
3.2 Global Top Cold Chain Services for Innovative Drug Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Cold Chain Services for Innovative Drug Revenue
3.4 Global Cold Chain Services for Innovative Drug Market Concentration Ratio
3.4.1 Global Cold Chain Services for Innovative Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cold Chain Services for Innovative Drug Revenue in 2025
3.5 Global Key Players of Cold Chain Services for Innovative Drug Head Offices and Areas Served
3.6 Global Key Players of Cold Chain Services for Innovative Drug, Products and Applications
3.7 Global Key Players of Cold Chain Services for Innovative Drug, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Cold Chain Services for Innovative Drug Breakdown Data by Type
4.1 Global Cold Chain Services for Innovative Drug Historic Market Size by Type (2021–2026)
4.2 Global Cold Chain Services for Innovative Drug Forecasted Market Size by Type (2027–2032)
5 Cold Chain Services for Innovative Drug Breakdown Data by Application
5.1 Global Cold Chain Services for Innovative Drug Historic Market Size by Application (2021–2026)
5.2 Global Cold Chain Services for Innovative Drug Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Cold Chain Services for Innovative Drug Market Size (2021–2032)
6.2 North America Cold Chain Services for Innovative Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Cold Chain Services for Innovative Drug Market Size by Country (2021–2026)
6.4 North America Cold Chain Services for Innovative Drug Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cold Chain Services for Innovative Drug Market Size (2021–2032)
7.2 Europe Cold Chain Services for Innovative Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Cold Chain Services for Innovative Drug Market Size by Country (2021–2026)
7.4 Europe Cold Chain Services for Innovative Drug Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cold Chain Services for Innovative Drug Market Size (2021–2032)
8.2 Asia-Pacific Cold Chain Services for Innovative Drug Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Cold Chain Services for Innovative Drug Market Size by Region (2021–2026)
8.4 Asia-Pacific Cold Chain Services for Innovative Drug Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cold Chain Services for Innovative Drug Market Size (2021–2032)
9.2 Latin America Cold Chain Services for Innovative Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Cold Chain Services for Innovative Drug Market Size by Country (2021–2026)
9.4 Latin America Cold Chain Services for Innovative Drug Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cold Chain Services for Innovative Drug Market Size (2021–2032)
10.2 Middle East & Africa Cold Chain Services for Innovative Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Cold Chain Services for Innovative Drug Market Size by Country (2021–2026)
10.4 Middle East & Africa Cold Chain Services for Innovative Drug Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Marken
11.1.1 Marken Company Details
11.1.2 Marken Business Overview
11.1.3 Marken Cold Chain Services for Innovative Drug Introduction
11.1.4 Marken Revenue in Cold Chain Services for Innovative Drug Business (2021–2026)
11.1.5 Marken Recent Development
11.2 World Courier
11.2.1 World Courier Company Details
11.2.2 World Courier Business Overview
11.2.3 World Courier Cold Chain Services for Innovative Drug Introduction
11.2.4 World Courier Revenue in Cold Chain Services for Innovative Drug Business (2021–2026)
11.2.5 World Courier Recent Development
11.3 Cryoport
11.3.1 Cryoport Company Details
11.3.2 Cryoport Business Overview
11.3.3 Cryoport Cold Chain Services for Innovative Drug Introduction
11.3.4 Cryoport Revenue in Cold Chain Services for Innovative Drug Business (2021–2026)
11.3.5 Cryoport Recent Development
11.4 DTW Logistics
11.4.1 DTW Logistics Company Details
11.4.2 DTW Logistics Business Overview
11.4.3 DTW Logistics Cold Chain Services for Innovative Drug Introduction
11.4.4 DTW Logistics Revenue in Cold Chain Services for Innovative Drug Business (2021–2026)
11.4.5 DTW Logistics Recent Development
11.5 City Express
11.5.1 City Express Company Details
11.5.2 City Express Business Overview
11.5.3 City Express Cold Chain Services for Innovative Drug Introduction
11.5.4 City Express Revenue in Cold Chain Services for Innovative Drug Business (2021–2026)
11.5.5 City Express Recent Development
11.6 Shanghai Shengsheng Pharmaceutical Cold Chain Technology
11.6.1 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Company Details
11.6.2 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Business Overview
11.6.3 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Cold Chain Services for Innovative Drug Introduction
11.6.4 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Revenue in Cold Chain Services for Innovative Drug Business (2021–2026)
11.6.5 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Recent Development
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Details
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher Cold Chain Services for Innovative Drug Introduction
11.7.4 Thermo Fisher Revenue in Cold Chain Services for Innovative Drug Business (2021–2026)
11.7.5 Thermo Fisher Recent Development
11.8 SF Express
11.8.1 SF Express Company Details
11.8.2 SF Express Business Overview
11.8.3 SF Express Cold Chain Services for Innovative Drug Introduction
11.8.4 SF Express Revenue in Cold Chain Services for Innovative Drug Business (2021–2026)
11.8.5 SF Express Recent Development
11.9 Catalent
11.9.1 Catalent Company Details
11.9.2 Catalent Business Overview
11.9.3 Catalent Cold Chain Services for Innovative Drug Introduction
11.9.4 Catalent Revenue in Cold Chain Services for Innovative Drug Business (2021–2026)
11.9.5 Catalent Recent Development
11.10 CIMC Cold Cloud
11.10.1 CIMC Cold Cloud Company Details
11.10.2 CIMC Cold Cloud Business Overview
11.10.3 CIMC Cold Cloud Cold Chain Services for Innovative Drug Introduction
11.10.4 CIMC Cold Cloud Revenue in Cold Chain Services for Innovative Drug Business (2021–2026)
11.10.5 CIMC Cold Cloud Recent Development
11.11 Guoyuan Life Sciences Group
11.11.1 Guoyuan Life Sciences Group Company Details
11.11.2 Guoyuan Life Sciences Group Business Overview
11.11.3 Guoyuan Life Sciences Group Cold Chain Services for Innovative Drug Introduction
11.11.4 Guoyuan Life Sciences Group Revenue in Cold Chain Services for Innovative Drug Business (2021–2026)
11.11.5 Guoyuan Life Sciences Group Recent Development
11.12 Rochin Logistics
11.12.1 Rochin Logistics Company Details
11.12.2 Rochin Logistics Business Overview
11.12.3 Rochin Logistics Cold Chain Services for Innovative Drug Introduction
11.12.4 Rochin Logistics Revenue in Cold Chain Services for Innovative Drug Business (2021–2026)
11.12.5 Rochin Logistics Recent Development
11.13 Azenta
11.13.1 Azenta Company Details
11.13.2 Azenta Business Overview
11.13.3 Azenta Cold Chain Services for Innovative Drug Introduction
11.13.4 Azenta Revenue in Cold Chain Services for Innovative Drug Business (2021–2026)
11.13.5 Azenta Recent Development
11.14 Saroute
11.14.1 Saroute Company Details
11.14.2 Saroute Business Overview
11.14.3 Saroute Cold Chain Services for Innovative Drug Introduction
11.14.4 Saroute Revenue in Cold Chain Services for Innovative Drug Business (2021–2026)
11.14.5 Saroute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Cold Chain Services for Innovative Drug market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 142
USD 4900.00
(Single User License)
The global Cold Chain Services for Innovative Drug market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 95
USD 4250.00
(Single User License)
The global market for Cold Chain Services for Innovative Drug was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 120
USD 3950.00
(Single User License)
The global Cold Chain Services for Innovative Drug market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 99
USD 4250.00
(Single User License)
The global Cold Chain Services for Innovative Drug market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 136
USD 4900.00
(Single User License)
The global market for Cold Chain Services for Innovative Drug was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 102
USD 3950.00
(Single User License)
The global market for Cold Chain Services for Innovative Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-12
Pages: 81
USD 2900.00
(Single User License)
Cold chain services for innovative drug development refer to temperature-controlled transportation and storage solutions specifically designed for temperature-sensitive drugs, samples, or reagents during the drug development process. These services ensure that drugs and related materials under research maintain optimal temperature conditions throughout the logistics process, preventing any compromise in their activity, stability, or quality due to external temperature fluctuations. The service typically includes refrigerated, frozen, and ultra-low temperature storage, and is applicable to clinical trials, laboratory research, and drug manufacturing.
Published Date: 2024-09-28
Pages: 137
USD 4900.00
(Single User License)
Cold chain services for innovative drug development refer to temperature-controlled transportation and storage solutions specifically designed for temperature-sensitive drugs, samples, or reagents during the drug development process. These services ensure that drugs and related materials under research maintain optimal temperature conditions throughout the logistics process, preventing any compromise in their activity, stability, or quality due to external temperature fluctuations. The service typically includes refrigerated, frozen, and ultra-low temperature storage, and is applicable to clinical trials, laboratory research, and drug manufacturing.
Published Date: 2024-09-28
Pages: 115
USD 3950.00
(Single User License)
Cold chain services for innovative drug development refer to temperature-controlled transportation and storage solutions specifically designed for temperature-sensitive drugs, samples, or reagents during the drug development process. These services ensure that drugs and related materials under research maintain optimal temperature conditions throughout the logistics process, preventing any compromise in their activity, stability, or quality due to external temperature fluctuations. The service typically includes refrigerated, frozen, and ultra-low temperature storage, and is applicable to clinical trials, laboratory research, and drug manufacturing.
Published Date: 2024-09-28
Pages: 82
USD 2900.00
(Single User License)
The global Cold Chain Services for Innovative Drug market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 142
The global Cold Chain Services for Innovative Drug market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 95
The global market for Cold Chain Services for Innovative Drug was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 120
The global Cold Chain Services for Innovative Drug market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 99
The global Cold Chain Services for Innovative Drug market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 136
The global market for Cold Chain Services for Innovative Drug was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 102
The global market for Cold Chain Services for Innovative Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-12
Pages: 81
Cold chain services for innovative drug development refer to temperature-controlled transportation and storage solutions specifically designed for temperature-sensitive drugs, samples, or reagents during the drug development process. These services ensure that drugs and related materials under research maintain optimal temperature conditions throughout the logistics process, preventing any compromise in their activity, stability, or quality due to external temperature fluctuations. The service typically includes refrigerated, frozen, and ultra-low temperature storage, and is applicable to clinical trials, laboratory research, and drug manufacturing.
Published: 2024-09-28
Pages: 137
Cold chain services for innovative drug development refer to temperature-controlled transportation and storage solutions specifically designed for temperature-sensitive drugs, samples, or reagents during the drug development process. These services ensure that drugs and related materials under research maintain optimal temperature conditions throughout the logistics process, preventing any compromise in their activity, stability, or quality due to external temperature fluctuations. The service typically includes refrigerated, frozen, and ultra-low temperature storage, and is applicable to clinical trials, laboratory research, and drug manufacturing.
Published: 2024-09-28
Pages: 115
Cold chain services for innovative drug development refer to temperature-controlled transportation and storage solutions specifically designed for temperature-sensitive drugs, samples, or reagents during the drug development process. These services ensure that drugs and related materials under research maintain optimal temperature conditions throughout the logistics process, preventing any compromise in their activity, stability, or quality due to external temperature fluctuations. The service typically includes refrigerated, frozen, and ultra-low temperature storage, and is applicable to clinical trials, laboratory research, and drug manufacturing.
Published: 2024-09-28
Pages: 82
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now